Contact Us

(206) 223-2319

Published Digestive Disease Articles

The quality, multidisciplinary patient care and original research of the Digestive Disease Institute team is published and presented each year in hundreds of original papers and book chapters and at regional, national and international conferences. See a partial list of recent articles, abstracts and book chapters below. Additionally, the Digestive Disease Institute sponsors numerous patient databases, ranging in topic from Inflammatory Bowel Disease to Colon Cancer Screening, that supports both research and patient quality initiatives.

Esophageal Disorders

  1. Boshier PR, Woodward C, Nikravan S, Neal JM, Warren D, Low DE. Selective Epidurography for the Assessment of Epidural Catheter Placement After Esophagectomy. Ann Thorac Surg. 2019;108:905-911.
  2. Boshier PR, Low DE. Commentary: Per oral endoscopic myotomy (POEM): Should it now be considered the first-line therapeutic approach for patients with achalasia? J Thorac Cardiovasc Surg. 2019;158:953-954. Epub 2019 Jan 11.
  3. Hagens ERC, van Berge Henegouwen MI, van Sandick JW, Cuesta MA, van der Peet DL, Heisterkamp J, Nieuwenhuijzen GAP, Rosman C, Scheepers JJG, Sosef MN, van Hillegersberg R, Lagarde SM, Nilsson M, Räsänen J, Nafteux P, Pattyn P, Hölscher AH, Schröder W, Schneider PM, Mariette C, Castoro C, Bonavina L, Rosati R, de Manzoni G, Mattioli S, Garcia JR, Pera M, Griffin M, Wilkerson P, Chaudry MA, Sgromo B, Tucker O, Cheong E, Moorthy K, Walsh TN, Reynolds J, Tachimori Y, Inoue H, Matsubara H, Kosugi SI, Chen H, Law SYK, Pramesh CS, Puntambekar SP, Murthy S, Linden P, Hofstetter WL, Kuppusamy MK, Shen KR, Darling GE, Sabino FD, Grimminger PP, Meijer SL, Bergman JJGHM, Hulshof MCCM, van Laarhoven HWM, Mearadji B, Bennink RJ, Annema JT, Dijkgraaf MGW, Gisbertz SS. Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study. BMC Cancer. 2019;19:662.
  4. Jayaraj M, Mohan BP, Mashiana H, Krishnamoorthi R, Adler DG. Safety and efficacy of combined antegrade and retrograde endoscopic dilation for complete esophageal obstruction: a systematic review and meta-analysis. Ann Gastroenterol. 2019;32:361-9.
  5. Klevebro F, Boshier PR, Low DE. Application of standardized hemodynamic protocols within enhanced recovery after surgery programs to improve outcomes associated with anastomotic leak and conduit necrosis in patients undergoing esophagectomy. J Thorac Dis 2019;11(Suppl 5):S692-S701. Review
  6. Konradsson M, van Berge Henegouwen MI, Bruns C, Chaudry MA, Cheong E, Cuesta MA, Darling GE, Gisbertz SS, Griffin SM, Gutschow CA, van Hillegersberg R, Hofstetter W, Hölscher AH, Kitagawa Y, van Lanschot JJB, Lindblad M, Ferri LE, Low DE, Luyer MDP, Ndegwa N, Mercer S, Moorthy K, Morse CR, Nafteux P, Nieuwehuijzen GAP, Pattyn P, Rosman C, Ruurda JP, Räsänen J, Schneider PM, Schröder W, Sgromo B, Van Veer H, Wijnhoven BPL, Nilsson M. Diagnostic criteria and symptom grading for delayed gastric conduit emptying after esophagectomy for cancer: international expert consensus based on a modified Delphi process. Dis Esophagus. 2019 Oct 11. pii: doz074. [Epub ahead of print]
  7. Krishnamoorthi R, Mohan BP, Jayaraj M, Wang KK, Katzka DA, Ross A, Adler DG, Iyer PG. Risk of progression in Barrett’s esophagus indefinite for dysplasia: a systematic review and meta-analysis. Gastrointest Endosc. 2019 Aug 14. pii: S0016-5107(19)32121-2.
  8. Linden PA, Towe CW, Watson TJ, Low DE, Cassivi SD, Grau-Sepulveda M, Worrell SG, Perry Y. Mortality After Esophagectomy: Analysis of Individual Complications and Their Association with Mortality. J Gastrointest Surg. 2019 Aug 13. [Epub ahead of print]
  9. Low DE, Kuppusamy MK, Alderson D, Cecconello I, Chang AC, Darling G, Davies A, D'Journo XB, Gisbertz SS, Griffin SM, Hardwick R, Hoelscher A, Hofstetter W, Jobe B, Kitagawa Y, Law S, Mariette C, Maynard N, Morse CR, Nafteux P, Pera M, Pramesh CS, Puig S, Reynolds JV, Schroeder W, Smithers M, Wijnhoven BPL. Benchmarking Complications Associated with Esophagectomy. Ann Surg. 2019;269:291-8.
  10. Low DE, Allum W, De Manzoni G, Ferri L, Immanuel A, Kuppusamy MK, Law SY, Lindblad M, Maynard N, Neal J, Pramesh CS, Scott M, Smithers BM, Addor V, Ljungqvist O. Guidelines for Perioperative Care in Esophagectomy: Enhanced Recovery after Surgery (ERAS®) Society Recommendations. World J Surg. 2019;43:299-330.
  11. Low DE, Wirsching A. Use of High Resolution Manometry: In reply to Siboni and colleagues. J Am Coll Surg. 2019;228:212.
  12. Mohan BP, Krishnamoorthi R, Ponnada S, Shakhatreh M, Jayaraj M, Garg R, Law J, Larsen M, Irani S, Ross A, Adler DG. Liquid Nitrogen Spray Cryotherapy in Treatment of Barrett's Esophagus, where do we stand? A Systematic Review and Meta-Analysis. Dis Esophagus. 2019;32:1-9.
  13. Wirsching A, Boshier PR, Krishnamoorthi R, Larsen MC, Irani S, Ross AS, Low DE. Endoscopic therapy and surveillance versus esophagectomy for early esophageal adenocarcinoma: A review of early outcomes and cost analysis. Am J Surg. 2019;218:164-69.
  14. Wirsching A, Boshier PR, Krishnamoorthi R, Larsen MC, Irani S, Ross AS, Low DE. Endoscopic therapy and surveillance versus esophagectomy for early esophageal adenocarcinoma: A review of early outcomes and cost analysis. Am J Surg. 2019 Jan 3. pii: S0002-9610(18)31225-X.
  15. Wirsching A, Klevebro F, Boshier PR, Hubka M, Kuppusamy MK, Kirtland SH, Low DE. The other explanation for dyspnea: giant paraesophageal hiatal hernia repair routinely improves pulmonary function. Dis Esophagus. 201913;32.
  16. Wirsching A, Boshier PR, Klevebro F, Kaplan SJ, Seesing MF, El-Moslimany R, Ross A, Low DE. Comparison of costs and short-term clinical outcomes of per-oral endoscopic myotomy and laparoscopic Heller myotomy. Am J Surg. 2019;218:706-711. Epub 2019 Jul 18.

Inflammatory Bowel Disease

  1. Boden EK, Canavan JB, Moran CJ, McCann K, Dunn WA, Farraye FA, Ananthakrishnan AN, Yajnik V, Gandhi R, Nguyen DD, Bhan AK, Weiner HL, Korzenik JR, Snapper SB. Immunologic Alterations Associated With Oral Delivery of Anti-CD3 (OKT3) Monoclonal Antibodies in Patients With Moderate-to-Severe Ulcerative Colitis. Crohns Colitis 360. 2019;1:otz009.
  2. Sandborn WJ, Peyrin-Biroulet L, Zhang J, Chiorean M, Vermeire S, Lee SD, Kühbacher T, Yacyshyn B, Cabell CH, Naik SU, Klassen P, Panés J. Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients with Ulcerative Colitis. Gastroenterology. 2019 Nov 8. pii: S0016-5085(19)41526-6.

Liver Disorders

  1. Chiorean MV. Metal and glue: best treatment choice for gastric varices? Endoscopy. 2019;51:913-14.
  2. Halls MC, Alseidi A, Berardi G, Cipriani F, Van der Poel M, Davila D, Ciria R, Besselink M, D'Hondt M, Dagher I, Alrdrighetti L, Troisi RI, Abu Hilal M. A Comparison of the Learning Curves of Laparoscopic Liver Surgeons in Differing Stages of the IDEAL Paradigm of Surgical Innovation: Standing on the Shoulders of Pioneers. Ann Surg. 2019;269:221-28.
  3. Pham C, Kuo A. Minority Report: ENUMERATing Treatment of Chronic HBV Infection Among Asian-American Communities. Dig Dis Sci. 2019;64:289-91.
  4. Melstrom LG, Eng OS, Raoof M, Singh G, Fong Y, Latorre K, Choi GH, Salem R, Bentrem DJ, Lewandowski R, Makris E, Poultsides G, Dhar VK, Chadalavada S, Shah SA, Johnson AC, Sekhar A, Kies D, Maithel SK, Rocha F, Alseidi A, Hagendoorn J, Borel Rinkes IHM, Fisher AV, Ronnekleiv-Kelly S, Weber SM, Winslow ER, Abbott DE. Is hepatectomy safe following Yttrium-90 therapy? A multi-institutional international experience. HPB (Oxford). 2019;21:1520-6.
  5. Poordad F, Bennett M, Sepe TE, Cohen E, Reindollar RW, Everson G, Phillips RW, Siddique A, Sullivan JG, Pilot-Matias T, Abunimeh M, Cohen DE, Younes Z. Ombitasvir/paritaprevir/ritonavir and dasabuvir with or without sofosbuvir for patients with hepatitis C virus genotype 1 infection who failed a prior course of direct-acting antiviral therapy. J Med Virol. 2019;91:1307-12.
  6. Rashidian N, Willaert W, Giglio MC, Scuderi V, Tozzi F, Vanlander A, D'Herde K, Alseidi A, Troisi RI. Laparoscopic Liver Surgery Training Course on Thiel-Embalmed Human Cadavers: Program Evaluation, Trainer's Long-Term Feedback and Steps Forward. World J Surg. 2019;43:2902-8.
  7. Rekman JF, Smith P, Bonds M, Coy D, Helton S. Current Imaging Standards for Nonmetastatic Benign and Malignant Liver Tumors. Surg Oncol Clin N Am. 2019;28:539-72.
  8. Whooley PD, Flores JP, Fotoohi M, Lin BS. Palliative TACE for hepatic metastases of chromophobe renal cell carcinoma. BMJ Case Rep. 2019 Jul 15;12(7). pii: e229207.

Pancreatic — Biliary System

  1. Asbun HJ, Moekotte AL, Vissers FL, Kunzler F, Cipriani F, Alseidi A, et al. The Miami International Evidence-Based Guidelines on Minimally Invasive Pancreas Resection. Ann Surg. 2019;271:1-14
  2. Coté GA, Durkalski-Mauldin VL, Serrano J, Klintworth E, Williams AW, Cruz-Monserrate Z, Arain M, Buxbaum JL, Conwell DL, Fogel EL, Freeman ML, Gardner TB, van Geenen E, Groce JR, Jonnalagadda SS, Keswani RN, Menon S, Moffatt DC, Papachristou GI, Ross A, Tarnasky PR, Wang AY, Wilcox CM, Hamilton F, Yadav D; SHARP Consortium. SpHincterotomy for Acute Recurrent Pancreatitis Randomized Trial: Rationale, Methodology, and Potential Implications. Pancreas. 2019;48:1061-7.
  3. Deal SB, Rich JA, Carlson E, Chevrollier GS, Pucci MJ, Alseidi AA. Patients support transfer of care for unexpected findings in laparoscopic cholecystectomy. Surg Endosc. 2019 Sep 3. doi: 10.1007/s00464-019-07087-0. [Epub ahead of print]
  4. Domínguez-Rosado I, Espinoza JL, Alvarez FA, Vintimilla A, Quintero M, Barzallo D, Pekolj J, Gondolesi G, Schelotto PB, Herman P, Carneiro D'Albuquerque LA, Andraus W, Padilla J, Jarufe N, Chapa O, Mercado M, Chan C, Alseidi A. Fellows perspective of HPB training in Latin America. HPB (Oxford). 2019 Jul 2. pii: S1365-182X(19)30566-0. doi: 10.1016/j.hpb.2019.05.016. [Epub ahead of print]
  5. Fisher AV, Lopez-Aguiar AG, Rendell VR, Pokrzywa C, Rocha FG, Kanji ZS, Poultsides GA, Makris EA, Dillhoff ME, Beal EW, Fields RC, Panni RZ, Idrees K, Smith PM, Cho CS, Beems MV, Maithel SK, Winslow ER, Abbott DE, Weber SM. Predictive Value of Chromogranin A and a Pre-Operative Risk Score to Predict Recurrence After Resection of Pancreatic Neuroendocrine Tumors. J Gastrointest Surg. 2019;23:651-8.
  6. Hyun JJ, Sahar N, Singla A, Ross AS, Irani SS, Gan SI, Larsen MC, Kozarek RA, Gluck M. Outcomes of Infected versus Symptomatic Sterile Walled-Off Pancreatic Necrosis Treated with a Minimally Invasive Therapy. Gut Liver. 2019;13:215-22.
  7. Irani S. Endoscopic Management of Gallbladder Disease. Gastroenterol Hepatol (N Y). 2019;15:210-2.
  8. Kanji ZS, Rocha FG. Premalignant Lesions of the Biliary Tract. Surg Clin North Am. 2019;99:301-14. Review.
  9. Krishnamoorthi R, Ross A. Endoscopic Management of Biliary Disorders: Diagnosis and Therapy. Surg Clin North Am. 2019;99:369-86.
  10. Muthusamy VR, Bruno MJ, Kozarek RA, Petersen BT, Pleskow DK, Sejpal DV, Slivka A, Peetermans JA, Rousseau MJ, Tirrell GP, Ross AS. Clinical evaluation of a single-use duodenoscope for endoscopic retrograde cholangiopancreatography. Clin Gastroenterol Hepatol. 2019 Nov 6. pii: S1542-3565(19)31261-3.
  11. Sahar N, Ross A, Lakhtakia S, Coté GA, Neuhaus H, Bruno MJ, Haluszka O, Kozarek R, Ramchandani M, Beyna T, Poley JW, Maranki J, Freeman M, Kedia P, Tarnasky P; Pancreatic Stenting Registry Group. Reducing the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis using 4-Fr pancreatic plastic stents placed with common-type guidewires: Results from a prospective multinational registry. Dig Endosc. 2019;31:299-306.
  12. Teoh AY, Perez-Miranda M, Kunda R, Lee SS, Irani S, Yeaton P, Sun S, Baron TH, Moon JH, Holt B, Khor CJL, Rerknimitr R, Bapaye A, Chan SM, Choi HJ, James TW, Kongkam P, Lee YN, Parekh P, Ridtitid W, Serna-Higuera C, Tan DMY, Torres-Yuste R. Outcomes of an international multicenter registry on EUS-guided gallbladder drainage in patients at high risk for cholecystectomy. 2019;7:E964-E73.
  13. Vivian E, Cler L, Conwell D, Coté GA, Dickerman R, Freeman M, Gardner TB, Hawes RH, Kedia P, Krishnamoorthi R, Oduor H, Pandol SJ, Papachristou GI, Ross A, Sethi A, Varadarajulu S, Vege SS, Wassef W, Wilcox CM, Whitcomb DC, Wu BU, Yadav D, Ellison A, Habash S, Rastegari S, Reddy R, Yen T, Brooks MR, Tarnasky P. Acute Pancreatitis Task Force on Quality: Development of Quality Indicators for Acute Pancreatitis Management. Am J Gastroenterol. 2019;114:1322-42.

Pancreas Cancer

  1. Bonds M, Rocha FG. Contemporary Review of Borderline Resectable Pancreatic Ductal Adenocarcinoma. J Clin Med. 2019 Aug 12;8(8).
  2. Chakedis J, Beal EW, Lopez-Aguilar A, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick B, Idress K, Maricola-Smith P, Cho C, Beems, M, Pawlik T, Maithel S, Schmidt C, Dilhof M. Surgery provides long-term survival in patients with metastatic neuroendocrine tumors undergoing resection for non-hormonal symptoms. J Gastrointest Surg. 2019;23:122-34.
  3. Dave A, Beal EW, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha FG, Kanji Z, Ronnekleiv-Kelly S, Rendell VR, Fields RC, Krasnick BA, Idrees K, Smith PM, Nathan H, Beems M, Maithel SK, Pawlik TM, Schmidt CR, Dillhoff ME. Evaluating the ACS NSQIP Risk Calculator in Primary Pancreatic Neuroendocrine Tumor: Results from the US Neuroendocrine Tumor Study Group. J Gastrointest Surg. 2019;23:2225-31.
  4. DePalo DK, Lee RM, Lopez-Aguiar AG, Gamboa AC, Rocha F, Poultsides G, Dillhoff M, Fields RC, Idrees K, Nathan H, Abbott D, Maithel SK, Russell MC; other members of the United States Neuroendocrine Tumor Study Group. Interaction of race and pathology for neuroendocrine tumors: Epidemiology, natural history, or racial disparity? J Surg Oncol. 2019;120:919-25.
  5. Dong DH, Zhang XF, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Pawlik TM; other members of the US Neuroendocrine Tumor Study Group. Impact of tumor size and nodal status on recurrence of nonfunctional pancreatic neuroendocrine tumors ≤2 cm after curative resection: A multi-institutional study of 392 cases. J Surg Oncol. 2019;120:1071-9.
  6. Dong DH, Zhang XF, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Dillhoff M, Maithel SK, Pawlik TM. Resection of pancreatic neuroendocrine tumors: defining patterns and time course of recurrence. HPB (Oxford). 2019 Jun 21. pii: S1365-182X(19)30570-2.
  7. Fisher AV, Lopez-Aguiar AG, Rendell VR, Pokrzywa C, Rocha FG, Kanji ZS, Poultsides GA, Makris EA, Dillhoff ME, Beal EW, Fields RC, Panni RZ, Idrees K, Smith PM, Cho CS, Beems MV, Maithel SK, Winslow ER, Abbott DE, Weber SM. Predictive Value of Chromogranin A and a Pre-Operative Risk Score to Predict Recurrence After Resection of Pancreatic Neuroendocrine Tumors. J Gastrointest Surg. 2019;23:651-8.
  8. Hong Peng, Ru Chen, Teresa A. Brentnall, Jimmy K. Eng, Vincent J. Picozzi, Sheng Pan. Predictive proteomic signatures for response of pancreatic cancer patients receiving chemotherapy. Clinical Proteomics 2019;16:31.
  9. Hu ZI, Bendell JC, Bullock A, LoConte NK, Hatoum H, Ritch P, Hool H, Leach JW, Sanchez J, Sohal DPS, Strickler J, Patel R, Wang-Gillam A, Firdaus I, Yu KH, Kapoun AM, Holmgren E, Zhou L, Dupont J, Picozzi V, Sahai V, O'Reilly EM. A randomized phase II trial of nab-paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer. Cancer Med. 2019;8:5148-57.
  10. Hyun JJ, Rose JB, Alseidi AA, Biehl TR, Helton S, Coy DL, Kozarek RA, Rocha FG. Significance of radiographic splenic vessel involvement in pancreatic ductal adenocarcinoma of the body and tail of the gland. J Surg Oncol. 2019;120:262-69.
  11. Kimbrough CW, Beal EW, Dillhoff ME, Schmidt CR, Pawlik TM, Lopez-Aguiar AG, Poultsides GA, Makris EA, Rocha F, Crown A, Abbott DE, Fisher AV, Fields FC, Krasnick BA, Idrees K, Smith PM, Cho CS, Beems M, Maithel SK, Cloyd JM. Influence of carcinoid syndrome on the clinical characteristics and outcomes of patients with gastroenteropancreatic neuroendocrine tumors undergoing surgical resection. Surgery. 2019;165:657-63.
  12. Le DT, Picozzi VJ, Ko AH, Wainberg ZA, Kindler H, Wang-Gillam A, Oberstein P, Morse MA, Zeh HJ 3rd, Weekes C, Reid T, Borazanci E, Crocenzi T, LoConte NK, Musher B, Laheru D, Murphy A, Whiting C, Nair N, Enstrom A, Ferber S, Brockstedt DG, Jaffee EM. Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study). Clin Cancer Res. 2019;25:5493-502.
  13. Lopez-Aguiar AG, Ethun CG, Zaidi MY, Rocha FG, Poultsides GA, Dillhoff M, Fields RC, Idrees K, Cho CS, Abbott DE, Cardona K, Maithel SK. The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical management. Surgery. 2019;166:15-21.
  14. Lopez-Aguiar AG, Zaidi MY, Beal EW, Dillhoff M, Cannon JGD, Poultsides GA, Kanji ZS, Rocha FG, Marincola Smith P, Idrees K, Beems M, Cho CS, Fisher AV, Weber SM, Krasnick BA, Fields RC, Cardona K, Maithel SK. Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group. Ann Surg Oncol. 2019;26:2517-24.
  15. Panni RZ, Lopez-Aguiar AG, Liu J, Poultsides GA, Rocha FG, Hawkins WG, Strasberg SM, Trikalinos NA, Maithel S, Fields RC; and other members of US-NETSG. Association of preoperative monocyte-to-lymphocyte and neutrophil-to-lymphocyte ratio with recurrence-free and overall survival after resection of pancreatic neuroendocrine tumors (US-NETSG). J Surg Oncol. 2019;120:632-8.
  16. Michael J. Pishvaian, Edik Matthew Blais, Patricia DeArbeloa, Jonathan Robert Brody, Lola Rahib, Andrew Eugene Hendifar, Sameh Mikhail, Vincent Chung, Davendra Sohal, Vincent J. Picozzi, Kimberly Mason, Lisa Tibbetts, Emily Lyons, Lynn McCormick Matrisian, Subha Madhavan, and Emanuel Petricoin. Improved overall survival (OS) for advanced pancreatic cancer (PDAC) patients (pts) enrolled in the Know Your Tumor (KYT) program whose tumors harbored highly actionable molecular alterations and who received molecularly-matched therapies (tx). Journal of Clinical Oncology 2019 37:15_suppl, 4138-4138.
  17. Rustgi SD, Amin S, Yang A, Kim MK, Nagula S, Kumta NA, DiMaio CJ, Boffetta P, Lucas AL. Preoperative Endoscopic Retrograde Cholangiopancreatography Is Not Associated With Increased Pancreatic Cancer Mortality. Clin Gastroenterol Hepatol. 2019;17:1580-1586.e4.
  18. Rustgi SD, Amin SP, Kim MK, Nagula S, Kumta NA, DiMaio CJ, Boffetta P, Lucas AL. Age, socioeconomic features, and clinical factors predict receipt of endoscopic retrograde cholangiopancreatography in pancreatic cancer. World J Gastrointest Endosc. 2019;11:133-44.
  19. Sahai V, Saif MW, Kalyan A, Philip PA, Rocha-Lima CM, Ocean A, Ondovik MS, Simeone DM, Banerjee S, Bhore R, Louis CU, Picozzi V. A Phase I/II Open-Label Multicenter Single-Arm Study of FABLOx (Metronomic 5-Fluorouracil Plus nab-Paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin) in Patients with Metastatic Pancreatic Cancer. J Pancreat Cancer. 2019;5:35-42.
  20. Seo DW, Sherman S, Dua KS, Slivka A, Roy A, Costamagna G, Deviere J, Peetermans J, Rousseau M, Nakai Y, Isayama H, Kozarek RA. Covered and Uncovered Biliary Metal Stents Provide Similar Relief of Biliary Obstruction During Neoadjuvant Therapy in Pancreatic Cancer – A randomized trial. Gastrointest Endosc. 2019;90:602-12.
  21. Tsang ES, Wong HL, Wang Y, Renouf DJ, Cheung WY, Lim HJ, Gill S, Loree JM, Kennecke HF. Outcomes and Characteristics of Patients Receiving Second-line Therapy for Advanced Pancreatic Cancer. Am J Clin Oncol. 2019;42:196-201.
  22. van Hilst J, de Rooij T, Klompmaker S, Rawashdeh M, Aleotti F, Al-Sarireh B, Alseidi A, Ateeb Z, Balzano G, Berrevoet F, Bjornsson B, Boggi U, Busch OR, Butturini G, Casadei R, Del Chiaro M, Chikhladze S, Cipriani F, van Dam R, Damoli I, van Dieren S, Dokmak S, Edwin B, van Eijck C, Fabre JM, Falconi M, Farges O, Fernandez-Cruz L, Forgione A, Frigerio I, Fuks D, Gavazzi F, Gayet B, Giardino A, Bas Groot K, Hackert T, Hassenpflug M, Kabir I, Keck T, Khatkov I, Kusar M, Lombardo C, Marchegiani G, Marshall R, Menon KV, Montorsi M, Orville M, de Pastena M, Pietrabissa A, Poves I, Primrose J, Pugliese R, Ricci C, Roberts K, Rosok B, Sahakyan MA, Sanchez-Cabus S, Sandstrom P, Scovel L, Solaini L, Soonawalla Z, Souche FR, Sutcliffe RP, Tiberio GA, Tomazic A, Troisi R, Wellner U, White S, Wittel UA, Zerbi A, Bassi C, Besselink MG, Abu Hilal M. Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA): A Pan-European Propensity Score Matched Study. Ann Surg. 2019;269:10-17.
  23. Wu L, Sahara K, Tsilimigras DI, Maithel SK, Poultsides GA, Rocha FG, Weber SM, Fields RC, Idrees K, Cho CS, Shen F, Pawlik TM; and other members of the U.S. Neuroendocrine Tumor Study Group. Therapeutic index of lymphadenectomy among patients with pancreatic neuroendocrine tumors: A multi-institutional analysis. J Surg Oncol. 2019;120:1080-6.
  24. Zaidi MY, Lopez-Aguiar AG, Switchenko JM, Lipscomb J, Andreasi V, Partelli S, Gamboa AC, Lee RM, Poultsides GA, Dillhoff M, Rocha FG, Idrees K, Cho CS, Weber SM, Fields RC, Staley CA 3rd, Falconi M, Maithel SK. A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients. Ann Surg. 2019;270:422-33.
  25. Zaidi MY, Lopez-Aguiar AG, Poultsides GA, Dillhoff M, Rocha FG, Idrees K, Nathan H, Winslow ER, Fields RC, Cardona K, Maithel SK; and other members of the US Neuroendocrine Tumor Study Group. The impact of failure to achieve symptom control after resection of functional neuroendocrine tumors: An 8-institution study from the US Neuroendocrine Tumor Study Group. J Surg Oncol. 2019;119:5-11.
  26. Zhang XF, Wu Z, Cloyd J, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Schmidt CR, Dillhoff M, Maithel SK, Pawlik TM. Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group. Surgery. 2019;165:548-56.
  27. Zhang XF, Wu Z, Cloyd J, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Schmidt CR, Dillhoff M, Maithel SK, Pawlik TM. Margin status and long-term prognosis of primary pancreatic neuroendocrine tumors after curative resection: Results from the US Neuroendocrine Tumor Study Group Surgery. 2019;165:548-56.
  28. Zhang XF, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Schmidt CR, Maithel SK, Pawlik TM; United States Neuroendocrine Tumor Study Group. Minimally invasive versus open distal pancreatectomy for pancreatic neuroendocrine tumors: An analysis from the U.S. neuroendocrine tumor study group. J Surg Oncol. 2019;120:231-40.
  29. Zhang XF, Xue F, Dong DH, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Lv Y, Maithel SK, Pawlik TM. New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors : A Multi-institutional and National Data Analysis. Ann Surg. 2019 Jul 26. doi: 10.1097/SLA.0000000000003478. [Epub ahead of print] PMID: 31356277

Small and Large Bowel

  1. Baison GN, Bonds MM, Helton WS, Kozarek RA. Choledochal cysts: Similarities and differences between Asian and Western countries. World J Gastroenterol. 2019;25:3334-43.
  2. Bushyhead D, Rocha FG, Kozarek RA. Small bowel necrosis after colonoscopy. Gastroenterology. 2019;156:e12-e13.
  3. Bushyhead D, Lin OST, Kozarek RA. A Review of the Management of Sporadic Colorectal Adenomas in Young People: Is Surveillance Wasted on the Young? Dig Dis Sci. 2019;64:2107-12.
  4. Chern YJ, Wong JCT, Cheng GSW, Yu A, Yin Y, Schaeffer DF, Kennecke HF, Morin G, Tai IT. The interaction between SPARC and GRP78 interferes with ER stress signaling and potentiates apoptosis via PERK/eIF2α and IRE1α/XBP-1 in colorectal cancer. Cell Death Dis. 2019;10:504.
  5. Crown A, Kennecke H, Kozarek R, Lopez-Aguiar AG, Dillhoff M, Beal EW, Poultsides GA, Makris E, Idrees K, Smith PM, Nathan H, Beems M, Abbott D, Fisher AV, Fields RC, Davidson J, Maithel SK, Rocha FG. Gastric carcinoids: Does type of surgery or tumor affect survival? Am J Surg. 2019;217:937-42.
  6. Crown A, Simianu VV, Kennecke H, Lopez-Aguiar AG, Dillhoff M, Beal EW, Poultsides GA, Makris E, Idrees K, Smith PM, Nathan H, Beems M, Abbott D, Barrett J, Fields RC, Davidson J, Maithel SK, Rocha FG. Appendiceal Neuroendocrine Tumors: Does Colon Resection Improve Outcomes? J Gastrointest Surg. 2019 Nov 20. doi: 10.1007/s11605-019-04431-6. [Epub ahead of print]
  7. Goodwin R, Jonker D, Chen E, Kennecke H, Cabanero M, Tsao MS, Vickers M, Bohemier C, Lim H, Ritter H, Tu D, Seymour L. A phase Ib study of a PI3Kinase inhibitor BKM120 in combination with panitumumab in patients with KRAS wild-type advanced colorectal cancer. Invest New Drugs. 2019 Sep 10. doi: 10.1007/s10637-019-00814-3. [Epub ahead of print]
  8. Jacobs JD, Kaplan SJ, Chiorean M. Spontaneous Pneumobilia and Hematemesis. Gastroenterology. 2019;157:e8-e9.
  9. Kim KO, Gluck M. Fecal Microbiota Transplantation: An Update on Clinical Practice. Clin Endosc. 2019;52:137-43.
  10. Kim KO, Schwartz MA, Lin OS, Chiorean MV, Gluck M. Reducing Cost and Complexity of Fecal Microbiota Transplantation Using Universal Donors for Recurrent Clostridium Difficile Infection. Adv Ther. 2019;36:2052-61.
  11. Kim KO, Kozarek RA, Gluck M, Ross AS, Lin OS. Changes in Lower Gastrointestinal Bleeding Presentation, Management, and Outcomes over a 10-Year Span. J Clin Gastroenterol. 2019;53:e463-e7.
  12. Kothari ST, Huang RJ, Shaukat A, Agrawal D, Buxbaum JL, Abbas Fehmi SM, Fishman DS, Gurudu SR, Khashab MA, Jamil LH, Jue TL, Law JK, Lee JK, Naveed M, Qumseya BJ, Sawhney MS, Thosani N, Yang J, DeWitt JM, Wani S; ASGE Standards of Practice Committee Chair. ASGE review of adverse events in colonoscopy. Gastrointest Endosc. 2019 Sep 25. pii: S0016-5107(19)32115-7.
  13. La Selva D, Kozarek RA, Dorer RK, Rocha FG, Gluck M. Primary and metastatic melanoma of the GI tract: clinical presentation, endoscopic findings, and patient outcomes. Surg Endosc. 2019 Oct 28. doi: 10.1007/s00464-019-07225-8. [Epub ahead of print]
  14. Lin OS, La Selva D, Kozarek RA, Tombs D, Weigel W, Beecher R, Koch J, McCormick S, Chiorean M, Drennan F, Gluck M, Venu N, Larsen MC, Ross AS. Computer-Assisted Propofol Sedation for Esophagogastroduodenoscopy is Effective, Efficient and Safe. Dig Dis Sci. 2019;64:3549-56.
  15. Simianu VV, Kumar AS. Surgical Care and Outcomes Assessment Program (SCOAP): A Nuanced, Flexible Platform for Colorectal Surgical Research. Clin Colon Rectal Surg. 2019;32:25-32.
  16. Thornblade LW, Simianu VV, Davidson GH, Flum DR. Elective Surgery for Diverticulitis and the Risk of Recurrence and Ostomy. Ann Surg. 2019 Oct 22. doi: 10.1097/SLA.0000000000003639. [Epub ahead of print]
  17. Weis JJ, Alseidi AA, Jeyarajah DR, Schweitzer MA, Hori Y, Cheung V, Scott DJ. Providing complex GI surgical care with minimally invasive approaches: a survey of the practice patterns of Fellowship Council alumni. Surg Endosc. 2019 Jun 17. doi: 10.1007/s00464-019-06929-1. [Epub ahead of print]
  18. Zaidi MY, Lopez-Aguiar AG, Dillhoff M, Beal E, Poultsides G, Makris E, Rocha F, Crown A, Idrees K, Marincola Smith P, Nathan H, Beems M, Abbott D, Barrett JR, Fields RC, Davidson J, Cardona K, Maithel SK. Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small-Bowel Neuroendocrine Tumors. JAMA Surg. 2019;154:134-40.
  19. Zaidi M, Lopez-Aguiar AG, Dillhoff ME, Beal EW, Poultsides GA, Makris EA, Rocha F, Crown A, Idrees K, Smith PM, Nathan H, Beems M, Abbott DE, Barrett JR, Fields RC, Davidson JT, Cardona K, Maithel SK. Prognostic role of lymph node positivity and number of lymph nodes needed for accurately staging small bowel neuroendocrine tumors. JAMA Surg. 2019;154:134-40.
  20. Zhang XF, Wu XN, Tsilimigras DI, Poultsides G, Rocha F, Abbott DE, Fields R, Idrees K, Cho C, Maithel SK, Pawlik TM; other members of the US Neuroendocrine Tumor Study Group. Duodenal neuroendocrine tumors: Impact of tumor size and total number of lymph nodes examined. J Surg Oncol. 2019;120:1302-10.

Other

  1. Bittner JG 4th, Logghe HJ, Kane ED, Goldberg RF, Alseidi A, Aggarwal R, Jacob BP. A Society of Gastrointestinal and Endoscopic Surgeons (SAGES) statement on closed social media (Facebook®) groups for clinical education and consultation: issues of informed consent, patient privacy, and surgeon protection. Surg Endosc.2019;33:1-7.
  2. Chen XP, Sullivan AM, Smink DS, Alseidi A, Bengtson JM, Kwakye G, Dalrymple JL. Resident Autonomy in the Operating Room: How Faculty Assess Real-time Entrustability. Ann Surg. 2019;269:1080-86.
  3. Cook MR, Hughes D, Deal SB, Sarap MD, Hughes TG, Deveney KE, Brasel KJ, Alseidi AA. When rural is no longer rural: Demand for subspecialty trained surgeons increases with increasing population of a non-metropolitan area. Am J Surg. 2019;218:1022-7.
  4. Hughes D, Cook MR, Deal SB, Hughes TG, Sarap M, Brasel K, Alseidi A. Rural surgeons' perspectives on necessity of post-residency training are stable across generations. Am J Surg. 2019;217:296-300.
  5. Nepomnayshy D, Whitledge J, Fitzgibbons S, Nijjar B, Gardner A, Alseidi A, Birkett R, Deal S, Duvra RR, Anton N, Stefanidis D. Advanced laparoscopic skills: Understanding the relationship between simulation-based practice and clinical performance. Am J Surg. 2019;218:527-32.
  6. Rekman JF, Alseidi A. Training for Minimally Invasive Cancer Surgery. Surg Oncol Clin N Am. 2019;28:11-30.
  7. Salles A, Milam L, Sevdalis N, Alseidi A, Mellinger J, Stefanidis D, Nahmias J, Kulaylat AN, Kim RH, Falcone JL, Arora TK, Phitayakorn R, Cochran A. Multi-institutional Surgical Education Interventions: A Scoping Review. Ann Surg. 2019;270:257-69.
  8. Sinit RB, Horan KL, Dorer RK, Aboulafia DM. Epstein-Barr Virus-Positive Mucocutaneous Ulcer: Case Report and Review of the First 100 Published Cases. Clin Lymphoma Myeloma Leuk. 2019;19:e81-e92.

Book Chapters

  1. AbouKhalil J and Rocha F. Biliary Cystic Neoplasms: Indications for Resection. In: Cardona K and Maithel SK, editors. Primary and Metastatic Liver Tumors, Springer 1st Edition
  2. Bains, Barbetta, Blackmon, et al. Esophagus. In: Operative Standards for Cancer Surgery: Volume 2: Thyroid, Gastric, Rectum, Esophagus, Melanoma. American College of Surgeons Clinical Research Program (Author), Matthew HG, Katz MD. (eds). 2019; pp. 249-375.
  3. Kanji Z and Rocha F. Premalignant lesions: IPNB, Choledochal Cysts, and Biliary Cystadenomas. In: Rose J, editor.  Biliary Disease, Surgical Clinics of North America. Elsevier
  4. Krepline A, Rocha F, Tsai S. Importance of Carbohydrate Antigen 19-9 Monitoring in the Management of Pancreatic Cancer In: Tsai, Rich, Erikson, Evans, editors, Management of Localized Pancreatic Cancer, Springer 2019;39-45
  5. Low DE, El Lakis MA. Modified Hill Repair for Gastroesophageal Reflux. In: Mastery of Surgery, 7th Edition. Fischer JE (ed), Wolters Kluwer, Philadelphia, PA, 2019; pp. 935-943.
  6. Singla A, Kozarek RA. Hilar Malignant Strictures, in Mine, T, Fujita, R (eds.), Advanced Therapeutic Endoscopy for Pancreatico-Biliary Diseases, Springer Japan KK, 2019, pp 285-302.